

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.55292475 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.55292475 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.22689358 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.21366949 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10358827 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.08633519 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83658067 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.61620146 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48841709 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48841709 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.48841709 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48841709 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.48841709 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48841709 |
| 15 | detection of bacterium (GO:0016045) | 4.42989749 |
| 16 | detection of other organism (GO:0098543) | 4.42384703 |
| 17 | response to peptidoglycan (GO:0032494) | 4.22307280 |
| 18 | leukocyte aggregation (GO:0070486) | 4.16282618 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.96357637 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96193869 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.92733950 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.84606038 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.84260675 |
| 24 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79324266 |
| 25 | positive thymic T cell selection (GO:0045059) | 3.77629799 |
| 26 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.77284076 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.73719887 |
| 28 | mannose metabolic process (GO:0006013) | 3.72092186 |
| 29 | thymic T cell selection (GO:0045061) | 3.62235619 |
| 30 | detection of external biotic stimulus (GO:0098581) | 3.61542974 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 3.57148502 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.55172276 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.54475617 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53519654 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.52439602 |
| 36 | germinal center formation (GO:0002467) | 3.47523826 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.45012322 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.38735803 |
| 39 | T cell selection (GO:0045058) | 3.37406659 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36150668 |
| 41 | cellular extravasation (GO:0045123) | 3.33567501 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.31880190 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.30879708 |
| 44 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.29053228 |
| 45 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.29053228 |
| 46 | detection of biotic stimulus (GO:0009595) | 3.19359600 |
| 47 | negative regulation of type 2 immune response (GO:0002829) | 3.19137277 |
| 48 | negative T cell selection (GO:0043383) | 3.18650756 |
| 49 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.17795615 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17066981 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16442011 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14882076 |
| 53 | regulation of leukocyte degranulation (GO:0043300) | 3.12916712 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.12378382 |
| 55 | response to type I interferon (GO:0034340) | 3.11675845 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.10117118 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.10117118 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07973818 |
| 59 | response to interleukin-15 (GO:0070672) | 3.07871241 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.05560830 |
| 61 | defense response to protozoan (GO:0042832) | 3.03668056 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.01892116 |
| 63 | regulation of B cell differentiation (GO:0045577) | 3.01583089 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99067773 |
| 65 | neutrophil activation (GO:0042119) | 2.98839404 |
| 66 | positive T cell selection (GO:0043368) | 2.97328556 |
| 67 | tolerance induction (GO:0002507) | 2.96743905 |
| 68 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93985211 |
| 69 | respiratory burst (GO:0045730) | 2.93532601 |
| 70 | regulation of tolerance induction (GO:0002643) | 2.90926115 |
| 71 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.88524513 |
| 72 | negative regulation of innate immune response (GO:0045824) | 2.86405128 |
| 73 | response to protozoan (GO:0001562) | 2.85012891 |
| 74 | response to host immune response (GO:0052572) | 2.84718152 |
| 75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.84718152 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 2.84559134 |
| 77 | granulocyte activation (GO:0036230) | 2.82242123 |
| 78 | T cell migration (GO:0072678) | 2.80349945 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78086061 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.78037792 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77449040 |
| 82 | response to host (GO:0075136) | 2.77449040 |
| 83 | response to host defenses (GO:0052200) | 2.77449040 |
| 84 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76736388 |
| 85 | negative regulation of phagocytosis (GO:0050765) | 2.76720162 |
| 86 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76672889 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.75782083 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73560169 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73477428 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.72367571 |
| 91 | response to laminar fluid shear stress (GO:0034616) | 2.72366782 |
| 92 | negative regulation of interleukin-6 production (GO:0032715) | 2.70647127 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70376836 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68405226 |
| 95 | regulation of type 2 immune response (GO:0002828) | 2.65930050 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65075415 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65075415 |
| 98 | signal complex assembly (GO:0007172) | 2.65031826 |
| 99 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.61501649 |
| 100 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.61212219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.45692364 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.36923791 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.05768672 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.75887837 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63486375 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.57956394 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55190526 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.51428843 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.50578845 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49492498 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48402618 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44324833 |
| 13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.41768309 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.38747405 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.34336308 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.32208532 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32154803 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25294184 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20457610 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15517138 |
| 21 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11294665 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10072652 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08010081 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07392475 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05217092 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04944660 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01276436 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.00580345 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.98097872 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88744613 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.88088846 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83856602 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.80973281 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77868260 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76364092 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75335393 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75003182 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70260399 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70082062 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.69077400 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67254340 |
| 42 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.65087114 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61000720 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60730258 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57546485 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57372515 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.56795801 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.55248135 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53667335 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.52203987 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50011448 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49922216 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47971138 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.46168552 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43195339 |
| 56 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42877072 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41383023 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39670522 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37539838 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.36630016 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36294823 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36274313 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34374127 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30991634 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29700807 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28680831 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27756782 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27211773 |
| 69 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24744570 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20411184 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19124600 |
| 72 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17665009 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17661581 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16795764 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16066508 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15859863 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15481412 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14980904 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12106493 |
| 80 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11962326 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11464959 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10634046 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06003072 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05702157 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05299516 |
| 86 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04938794 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04631110 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04358648 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03597382 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.03585272 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02402417 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01971615 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01017100 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00152442 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97769338 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97584175 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97129524 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96869993 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95148404 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94702887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.19321814 |
| 2 | MP0003303_peritoneal_inflammation | 3.45755920 |
| 3 | MP0003724_increased_susceptibility_to | 3.36316098 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.09337956 |
| 5 | MP0001790_abnormal_immune_system | 2.71864823 |
| 6 | MP0005387_immune_system_phenotype | 2.71864823 |
| 7 | MP0001800_abnormal_humoral_immune | 2.69836833 |
| 8 | MP0002419_abnormal_innate_immunity | 2.69691889 |
| 9 | MP0000685_abnormal_immune_system | 2.66421250 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.62512956 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.58598818 |
| 12 | MP0005025_abnormal_response_to | 2.58141036 |
| 13 | MP0005671_abnormal_response_to | 2.57991865 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.43463039 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.42968398 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.42635282 |
| 17 | MP0002723_abnormal_immune_serum | 2.33834639 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.29425844 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.28671339 |
| 20 | MP0001819_abnormal_immune_cell | 2.27599663 |
| 21 | MP0009785_altered_susceptibility_to | 2.27440337 |
| 22 | MP0008260_abnormal_autophagy | 2.24311228 |
| 23 | MP0009278_abnormal_bone_marrow | 2.17548723 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.11335291 |
| 25 | MP0004947_skin_inflammation | 2.09497776 |
| 26 | MP0006082_CNS_inflammation | 2.04119272 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.02620709 |
| 28 | MP0005451_abnormal_body_composition | 1.98867729 |
| 29 | MP0002405_respiratory_system_inflammati | 1.95781745 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.95179122 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.90364014 |
| 32 | MP0002398_abnormal_bone_marrow | 1.86059894 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.84313936 |
| 34 | MP0000716_abnormal_immune_system | 1.79933754 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.74236702 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.67563028 |
| 37 | MP0004510_myositis | 1.66803584 |
| 38 | MP0009840_abnormal_foam_cell | 1.58968323 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.57964447 |
| 40 | MP0001873_stomach_inflammation | 1.55089490 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.53595204 |
| 42 | MP0000858_altered_metastatic_potential | 1.53472582 |
| 43 | MP0002722_abnormal_immune_system | 1.52487538 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.51098300 |
| 45 | MP0002429_abnormal_blood_cell | 1.47577384 |
| 46 | MP0004381_abnormal_hair_follicle | 1.47297004 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.47292763 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.46698419 |
| 49 | MP0003866_abnormal_defecation | 1.45046531 |
| 50 | MP0003828_pulmonary_edema | 1.40905618 |
| 51 | MP0002132_abnormal_respiratory_system | 1.36528011 |
| 52 | MP0008469_abnormal_protein_level | 1.33370913 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.32258876 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.31541366 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.27502974 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.27502974 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.27185370 |
| 58 | MP0002933_joint_inflammation | 1.24911324 |
| 59 | MP0001849_ear_inflammation | 1.24515119 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.24466500 |
| 61 | MP0001851_eye_inflammation | 1.22528261 |
| 62 | MP0005310_abnormal_salivary_gland | 1.17560858 |
| 63 | MP0001853_heart_inflammation | 1.15957447 |
| 64 | MP0003091_abnormal_cell_migration | 1.09246843 |
| 65 | MP0009764_decreased_sensitivity_to | 1.08364715 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.05098988 |
| 67 | MP0000490_abnormal_crypts_of | 0.97748787 |
| 68 | MP0005390_skeleton_phenotype | 0.96586372 |
| 69 | MP0001663_abnormal_digestive_system | 0.95274007 |
| 70 | MP0003075_altered_response_to | 0.95267750 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 0.94319561 |
| 72 | MP0004858_abnormal_nervous_system | 0.90743827 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 0.90167701 |
| 74 | MP0005166_decreased_susceptibility_to | 0.89116638 |
| 75 | MP0002254_reproductive_system_inflammat | 0.88503444 |
| 76 | MP0005360_urolithiasis | 0.86946860 |
| 77 | MP0004883_abnormal_blood_vessel | 0.86896481 |
| 78 | MP0000604_amyloidosis | 0.84841912 |
| 79 | MP0003448_altered_tumor_morphology | 0.84309897 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.82911226 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.82845320 |
| 82 | MP0003690_abnormal_glial_cell | 0.82760855 |
| 83 | MP0003279_aneurysm | 0.80542060 |
| 84 | MP0005164_abnormal_response_to | 0.79667467 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.78663377 |
| 86 | MP0008004_abnormal_stomach_pH | 0.78439902 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.77630311 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.76030436 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.74545453 |
| 90 | MP0003795_abnormal_bone_structure | 0.74442105 |
| 91 | MP0004130_abnormal_muscle_cell | 0.71401291 |
| 92 | MP0000249_abnormal_blood_vessel | 0.71278950 |
| 93 | MP0001958_emphysema | 0.71119038 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.68001810 |
| 95 | MP0000343_altered_response_to | 0.66229972 |
| 96 | MP0005023_abnormal_wound_healing | 0.65519814 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.65333837 |
| 98 | MP0008874_decreased_physiological_sensi | 0.62736397 |
| 99 | MP0005409_darkened_coat_color | 0.62347200 |
| 100 | MP0000609_abnormal_liver_physiology | 0.61017300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.75028555 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.57671697 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.54674394 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.39918505 |
| 5 | Myositis (HP:0100614) | 4.30349040 |
| 6 | Orchitis (HP:0100796) | 3.85328731 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61154360 |
| 8 | Increased IgE level (HP:0003212) | 3.60599746 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.52035569 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.46163489 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.40925511 |
| 12 | Obstructive lung disease (HP:0006536) | 3.39726492 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39726492 |
| 14 | Optic neuritis (HP:0100653) | 3.39465362 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.39465362 |
| 16 | Meningitis (HP:0001287) | 3.38093106 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.31530713 |
| 18 | Cellulitis (HP:0100658) | 3.23861000 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.21195517 |
| 20 | Colitis (HP:0002583) | 3.16619327 |
| 21 | Gingivitis (HP:0000230) | 3.13107002 |
| 22 | Recurrent skin infections (HP:0001581) | 3.08690773 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.03266512 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.01083103 |
| 25 | Stomatitis (HP:0010280) | 3.00949662 |
| 26 | Pustule (HP:0200039) | 3.00875335 |
| 27 | Inflammation of the large intestine (HP:0002037) | 2.94699518 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.91536222 |
| 29 | Vasculitis (HP:0002633) | 2.90599295 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87677206 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87677206 |
| 32 | Recurrent viral infections (HP:0004429) | 2.87518517 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.85778285 |
| 34 | Encephalitis (HP:0002383) | 2.72979659 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.68136273 |
| 36 | Chest pain (HP:0100749) | 2.58261570 |
| 37 | Gastrointestinal stroma tumor (HP:0100723) | 2.51227866 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.48430880 |
| 39 | Epistaxis (HP:0000421) | 2.45592648 |
| 40 | Urticaria (HP:0001025) | 2.42946027 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.41531173 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.41037901 |
| 43 | Hypochromic anemia (HP:0001931) | 2.39304217 |
| 44 | Hemoptysis (HP:0002105) | 2.37012763 |
| 45 | Obstructive sleep apnea (HP:0002870) | 2.32745132 |
| 46 | Petechiae (HP:0000967) | 2.32052931 |
| 47 | Lymphopenia (HP:0001888) | 2.31609366 |
| 48 | Increased serum ferritin (HP:0003281) | 2.30867082 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.29680488 |
| 50 | Emphysema (HP:0002097) | 2.29581928 |
| 51 | Purpura (HP:0000979) | 2.28834059 |
| 52 | Thin bony cortex (HP:0002753) | 2.23620335 |
| 53 | Osteomyelitis (HP:0002754) | 2.21631109 |
| 54 | Malnutrition (HP:0004395) | 2.20205130 |
| 55 | Slow saccadic eye movements (HP:0000514) | 2.18167696 |
| 56 | Keratoconjunctivitis (HP:0001096) | 2.18142783 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.17595292 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14558266 |
| 59 | Granulocytopenia (HP:0001913) | 2.13820585 |
| 60 | Broad face (HP:0000283) | 2.11843076 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.10798057 |
| 62 | Premature loss of primary teeth (HP:0006323) | 2.08988885 |
| 63 | Loss of speech (HP:0002371) | 2.08594697 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.08370040 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07629610 |
| 66 | Mucopolysacchariduria (HP:0008155) | 2.07629610 |
| 67 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07299784 |
| 68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07299784 |
| 69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07299784 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06822138 |
| 71 | Restrictive lung disease (HP:0002091) | 2.04985313 |
| 72 | Amyloidosis (HP:0011034) | 2.04843181 |
| 73 | T lymphocytopenia (HP:0005403) | 2.04723210 |
| 74 | Gingival bleeding (HP:0000225) | 2.01401438 |
| 75 | Leukocytosis (HP:0001974) | 1.98885930 |
| 76 | Arterial thrombosis (HP:0004420) | 1.97729674 |
| 77 | Hepatosplenomegaly (HP:0001433) | 1.97721423 |
| 78 | Cerebral aneurysm (HP:0004944) | 1.97409556 |
| 79 | Peritonitis (HP:0002586) | 1.97216641 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96992992 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96992992 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96992992 |
| 83 | Metaphyseal cupping (HP:0003021) | 1.96296133 |
| 84 | Polygenic inheritance (HP:0010982) | 1.96277639 |
| 85 | Viral hepatitis (HP:0006562) | 1.96025242 |
| 86 | Papilloma (HP:0012740) | 1.95829115 |
| 87 | Verrucae (HP:0200043) | 1.95829115 |
| 88 | Easy fatigability (HP:0003388) | 1.95153351 |
| 89 | Pulmonary embolism (HP:0002204) | 1.94080311 |
| 90 | Episodic fever (HP:0001954) | 1.93844197 |
| 91 | Sepsis (HP:0100806) | 1.92623184 |
| 92 | Abnormality of the peritoneum (HP:0002585) | 1.90395738 |
| 93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89431616 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 1.88648400 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.88451567 |
| 96 | Abnormality of the pleura (HP:0002103) | 1.87582648 |
| 97 | Increased IgM level (HP:0003496) | 1.87309949 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 1.86279169 |
| 99 | Hypertriglyceridemia (HP:0002155) | 1.86202733 |
| 100 | Skin ulcer (HP:0200042) | 1.85374746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.92511399 |
| 2 | ERN1 | 3.53932655 |
| 3 | RIPK4 | 3.36140105 |
| 4 | PRPF4B | 3.23932094 |
| 5 | TRIB3 | 3.05302943 |
| 6 | MAP2K3 | 2.64600781 |
| 7 | SIK1 | 2.49566970 |
| 8 | TYK2 | 2.36069939 |
| 9 | BLK | 2.33054320 |
| 10 | IRAK4 | 2.26416698 |
| 11 | TNK2 | 2.09124653 |
| 12 | SMG1 | 1.91202231 |
| 13 | SIK3 | 1.88871467 |
| 14 | ZAP70 | 1.86571115 |
| 15 | MAP3K13 | 1.80996394 |
| 16 | GRK6 | 1.79662055 |
| 17 | CSK | 1.79239947 |
| 18 | MAP3K3 | 1.78197866 |
| 19 | MAP3K14 | 1.63845907 |
| 20 | FES | 1.61375539 |
| 21 | EPHB1 | 1.61362801 |
| 22 | SIK2 | 1.60380589 |
| 23 | MAP3K11 | 1.56508339 |
| 24 | TBK1 | 1.50779799 |
| 25 | BTK | 1.49533548 |
| 26 | TAOK1 | 1.49239183 |
| 27 | JAK3 | 1.43353387 |
| 28 | MARK2 | 1.40483259 |
| 29 | MAP3K10 | 1.39085562 |
| 30 | FGFR4 | 1.37257788 |
| 31 | CDC42BPA | 1.32496057 |
| 32 | HCK | 1.25828618 |
| 33 | ICK | 1.24744818 |
| 34 | IKBKE | 1.24276197 |
| 35 | MAP3K1 | 1.23461975 |
| 36 | RIPK1 | 1.20289271 |
| 37 | IRAK3 | 1.20256671 |
| 38 | PRKD2 | 1.15995193 |
| 39 | CDK12 | 1.15346386 |
| 40 | FGR | 1.14172587 |
| 41 | MARK3 | 1.11073892 |
| 42 | SYK | 1.10716582 |
| 43 | TAOK2 | 1.10570377 |
| 44 | PTK6 | 1.04049226 |
| 45 | MAP3K7 | 1.02648776 |
| 46 | CSF1R | 1.01246391 |
| 47 | JAK1 | 1.00473043 |
| 48 | TXK | 0.99856327 |
| 49 | MAP3K6 | 0.97072542 |
| 50 | HIPK2 | 0.91675047 |
| 51 | IKBKB | 0.88510893 |
| 52 | LYN | 0.86868940 |
| 53 | LCK | 0.86625610 |
| 54 | ITK | 0.85223469 |
| 55 | JAK2 | 0.82484398 |
| 56 | PDPK1 | 0.79060476 |
| 57 | KSR2 | 0.78963317 |
| 58 | IRAK2 | 0.78028038 |
| 59 | MAPK7 | 0.76277673 |
| 60 | NME2 | 0.76056942 |
| 61 | MAPK12 | 0.74337037 |
| 62 | PKN2 | 0.74223176 |
| 63 | PDK1 | 0.73790341 |
| 64 | RPS6KL1 | 0.71939683 |
| 65 | RPS6KC1 | 0.71939683 |
| 66 | MAP2K6 | 0.70115503 |
| 67 | KIT | 0.68421603 |
| 68 | TTN | 0.66317459 |
| 69 | MATK | 0.65554437 |
| 70 | DYRK1B | 0.64824137 |
| 71 | EEF2K | 0.63850944 |
| 72 | IRAK1 | 0.62535075 |
| 73 | FGFR3 | 0.61240095 |
| 74 | CDK4 | 0.60801226 |
| 75 | TGFBR2 | 0.59980396 |
| 76 | RPS6KA2 | 0.58478773 |
| 77 | BMX | 0.56874603 |
| 78 | RPS6KA6 | 0.56342634 |
| 79 | CAMKK1 | 0.55646266 |
| 80 | TESK2 | 0.55572745 |
| 81 | LRRK2 | 0.53951386 |
| 82 | TYRO3 | 0.51959609 |
| 83 | STK10 | 0.51573180 |
| 84 | MAP2K2 | 0.51191856 |
| 85 | MAPK11 | 0.47052483 |
| 86 | CHUK | 0.45791012 |
| 87 | RET | 0.45164898 |
| 88 | FYN | 0.43898958 |
| 89 | MTOR | 0.42867451 |
| 90 | YES1 | 0.38650376 |
| 91 | MAPKAPK2 | 0.38424297 |
| 92 | PDGFRB | 0.37208804 |
| 93 | MAP3K8 | 0.34053186 |
| 94 | STK38 | 0.33201554 |
| 95 | MAP3K2 | 0.33009957 |
| 96 | PAK4 | 0.32847083 |
| 97 | MAPK4 | 0.32394388 |
| 98 | PDGFRA | 0.31962497 |
| 99 | PRKCQ | 0.31401745 |
| 100 | TEC | 0.30837716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59936395 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.56306873 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.46738631 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34748927 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19788937 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.97253105 |
| 7 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.97125512 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96583787 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.92232311 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.83963662 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82723185 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82672847 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72356275 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.70523459 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69405272 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68662358 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62518264 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56528464 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53406088 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.51896598 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49670565 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.44559755 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42666668 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.42661699 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38719091 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38248905 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37733013 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.37456569 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35797146 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.35738871 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35098288 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35010093 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34319465 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33370551 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32991283 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32868779 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28714289 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.28321777 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27575666 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.20185487 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17966106 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13626190 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.12749880 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.10778952 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10305261 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07526658 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04009891 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03731261 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.03181910 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.01971944 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.97200479 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95037581 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.93699816 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.92383861 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91430780 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.90251507 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89038272 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.86890284 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86410508 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85156972 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84813877 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84042298 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83154931 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83119721 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.79221540 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78079108 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77839715 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77466816 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75200063 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.74135778 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73935998 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73514210 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71843040 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.71496577 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.71467378 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69714739 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67873830 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.67322797 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67236141 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65638025 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62936896 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59707614 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58648969 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58522459 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58481884 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57155461 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55876422 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55508804 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55258005 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54391250 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.52913998 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52286568 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.51920631 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.51436726 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51280867 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49766260 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48276627 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47941918 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47901399 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47887208 |

